You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 96 No. 3, March 1968 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment of Renal Allograft Rejection in Dogs

Combined Thoracic Duct Fistula and Immunosuppressive Chemotherapy

Rogelio E. Vega, MD; Ronald P. Daniele, BA; Alberto Chaya, MD; Hiroshi Mitsouka, MD; John M. Howard, MD

AMA Arch Surg. 1968;96(3):344-348.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

A previous study in this laboratory suggested that an external thoracic duct fistula could prolong the survival of canine renal allografts.1 The mechanism for this apparent interference with the transplant immunity might be the depletion in the population of immunologically competent lymphocytes resulting from uninterrupted drainage of the thoracic duct. Gowans has shown that lymphopenia can be brought about by prolonged drainage of the thoracic duct in rats.2 Others have reported similar findings in dogs.3

Although the role of the lymphocytes in transplant immunity has not been ascertained, it seems only reasonable to implicate them because of their consistent involvement in the antigen-antibody reaction. Their well documented presence at the site of the tissue graft rejection marks them teleologically as an intermediary in this phenomenon, specifically as carriers of antibodies. For this reason immunosuppressive drugs have been tested according to their ability to produce lymphopenia. Even some . . . [Full Text PDF of this Article]


Author Affiliations

From the Department of Surgery, Hahnemann Medical College, Philadelphia.


Footnotes

Submitted for publication July 18, 1967.

Reprint requests to 230 N Broad St, Philadelphia 19102 (Dr. Howard).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1968 American Medical Association. All Rights Reserved.